MRP ₹622
(Inclusive of all Taxes)
₹74.6 Cashback (12%)
Extra 15% Off with Bank Offers
Composition :
EMPAGLIFLOZIN-25MG
Manufacturer/Marketer :
Cipla Ltd
Consume Type :
Oral
Expires on or after :
Return Policy :
Not Returnable
Secure Payment
Trusted by 8 Crore Indians
Genuine Products
Author Details
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Alcohol
Pregnancy
Breast Feeding
Driving
Liver
Kidney
Children
Product Substitutes
Drug-Drug Interactions
Critical
EmpagliflozinMecamylamine
Severe
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Oboravo 25mg Tablet:
Coadministration of Oboravo 25mg Tablet with Gatifloxacin may sometimes affect blood glucose levels. Both high blood glucose and, less frequently, low blood glucose have been reported.
How to manage the interaction:
It is not recommended to take Oboravo 25mg Tablet with Gatifloxacinas it can result in an interaction, but it can be taken if advised by the doctor. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremors, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised. Do not discontinue any medication without consulting a doctor.
Coadministration of Oboravo 25mg Tablet with Gatifloxacin may sometimes affect blood glucose levels. Both high blood glucose and, less frequently, low blood glucose have been reported.
How to manage the interaction:
It is not recommended to take Oboravo 25mg Tablet with Gatifloxacinas it can result in an interaction, but it can be taken if advised by the doctor. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremors, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised. Do not discontinue any medication without consulting a doctor.
EmpagliflozinMecamylamine
Severe
How does the drug interact with Oboravo 25mg Tablet:
Combining Mecamylamine with Oboravo 25mg Tablet can increase the risk of side effects like dehydration and low blood pressure.
How to manage the interaction:
Although taking Mecamylamine and Oboravo 25mg Tablet together can cause an interaction, it can be taken if your doctor has suggested it. If you notice any of these signs like feeling very thirsty, having low blood pressure, a headache, feeling dizzy or lightheaded, or even fainting, make sure to contact a doctor right away. Do not stop using any medications without talking to a doctor.
Combining Mecamylamine with Oboravo 25mg Tablet can increase the risk of side effects like dehydration and low blood pressure.
How to manage the interaction:
Although taking Mecamylamine and Oboravo 25mg Tablet together can cause an interaction, it can be taken if your doctor has suggested it. If you notice any of these signs like feeling very thirsty, having low blood pressure, a headache, feeling dizzy or lightheaded, or even fainting, make sure to contact a doctor right away. Do not stop using any medications without talking to a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Drug-Diseases Interactions
EMPAGLIFLOZIN-25MGOther disorders of kidney and ureter, not elsewhere classified
Severe
EMPAGLIFLOZIN-25MGHypotension
Moderate
Drug-Diseases Interactions
Login/Sign Up
EMPAGLIFLOZIN-25MGOther disorders of kidney and ureter, not elsewhere classified
Severe
How does the disease interact with Oboravo 25mg Tablet:
In patients with decreasing renal function, the glucose-lowering benefits of sodium-glucose cotransporter 2 (SGLT2) inhibitors are reduced. In addition, those who have impaired renal function (eGFR less than 60 mL/min/1.73 m2), those who are old, and those on loop diuretics may be more susceptible to deleterious effects of volume depletion such hypotension and acute kidney damage. Prior to starting therapy, at-risk individuals should have their renal function assessed, and it should be followed up on often. Before starting treatment, determine the volume status and address volume depletion. It is not recommended to use SGLT-2 inhibitors in dialysis patients. SGLT2 inhibitor medication has been shown to have positive benefits on chronic renal disease and heart failure in persons with and without type 2 diabetes. The product labelling from the manufacturer has to be
How to manage the interaction:
Oboravo 25mg Tablet is contraindicated in patients undergoing dialysis.
In patients with decreasing renal function, the glucose-lowering benefits of sodium-glucose cotransporter 2 (SGLT2) inhibitors are reduced. In addition, those who have impaired renal function (eGFR less than 60 mL/min/1.73 m2), those who are old, and those on loop diuretics may be more susceptible to deleterious effects of volume depletion such hypotension and acute kidney damage. Prior to starting therapy, at-risk individuals should have their renal function assessed, and it should be followed up on often. Before starting treatment, determine the volume status and address volume depletion. It is not recommended to use SGLT-2 inhibitors in dialysis patients. SGLT2 inhibitor medication has been shown to have positive benefits on chronic renal disease and heart failure in persons with and without type 2 diabetes. The product labelling from the manufacturer has to be
How to manage the interaction:
Oboravo 25mg Tablet is contraindicated in patients undergoing dialysis.
EMPAGLIFLOZIN-25MGHypotension
Moderate
How does the disease interact with Oboravo 25mg Tablet:
Sodium-glucose cotransporter 2 (SGLT-2) inhibitors produce intravascular volume contraction, which may result in symptomatic hypotension following the start of medication, particularly in older patients, those with impaired renal function, those with low systolic blood pressure, and those using diuretics. Prior to beginning treatment, the volume status should be evaluated, rectified, and patients should be monitored closely.
How to manage the interaction:
Blood plasma volume should be assessed and corrected before starting treatment with Oboravo 25mg Tablet and patients should be monitored during therapy.
Sodium-glucose cotransporter 2 (SGLT-2) inhibitors produce intravascular volume contraction, which may result in symptomatic hypotension following the start of medication, particularly in older patients, those with impaired renal function, those with low systolic blood pressure, and those using diuretics. Prior to beginning treatment, the volume status should be evaluated, rectified, and patients should be monitored closely.
How to manage the interaction:
Blood plasma volume should be assessed and corrected before starting treatment with Oboravo 25mg Tablet and patients should be monitored during therapy.
EMPAGLIFLOZIN-25MGOther and unspecified infectious diseases
Moderate
How does the disease interact with Oboravo 25mg Tablet:
The usage of sodium-glucose cotransporter 2 (SGLT-2) inhibitors has been associated with an increased risk of genital mycotic infections. When administering this medication to patients who have a history of genital mycotic infections or who have not had circumcision, caution should be used since they are more susceptible to get genital mycotic infections. Observe and treat as necessary.
How to manage the interaction:
Oboravo 25mg Tablet should be used with caution in patients who have a history of genital mycotic infections (fungal infections of the urogenital area) or who are uncircumcised as these patients are more likely to develop genital mycotic infections.
The usage of sodium-glucose cotransporter 2 (SGLT-2) inhibitors has been associated with an increased risk of genital mycotic infections. When administering this medication to patients who have a history of genital mycotic infections or who have not had circumcision, caution should be used since they are more susceptible to get genital mycotic infections. Observe and treat as necessary.
How to manage the interaction:
Oboravo 25mg Tablet should be used with caution in patients who have a history of genital mycotic infections (fungal infections of the urogenital area) or who are uncircumcised as these patients are more likely to develop genital mycotic infections.
All Substitutes & Brand Comparisons
RX
Out of StockEmpaglyde 25 Tablet 10's
Mankind Pharma Pvt Ltd
₹92.5
(₹9.25 per unit)
83% CHEAPERRX
Out of StockEmpagreat 25 Tablet 10's
Mankind Pharma Pvt Ltd
₹92.5
(₹9.25 per unit)
83% CHEAPERRX
Out of StockEmpha 25 Tablet 10's
Intas Pharmaceuticals Ltd
₹111.5
(₹11.15 per unit)
79% CHEAPER
Have a query?